News

Filter

Current filters:

Kissei Pharmaceutical

Kissei collaborates with Alteogen on biosimilars

14-02-2014

Japanese drugmaker Kissei Pharmaceutical has entered into a business collaboration agreement with South…

BiosimilarsBiotechnologyKissei PharmaceuticalResearch

Norgine and Kissei’s Savene approved in Japan

21-01-2014

Independent Dutch firm Norgine and its Japanese partner Kissei Pharmaceutical received approval from…

Asia-PacificKissei PharmaceuticalNorgineOncologyPharmaceuticalRegulationSavene

Kissei and JCR conclude accord on biosimilar Aranesp

01-10-2013

Kissei Pharmaceutical and JCR Pharmaceuticals have announced the conclusion of a collaborative R&D agreement…

AmgenAranespAsia-PacificBiosimilarsGenericsJCR PharmaceuticalsKissei PharmaceuticalOncologyResearch

Indication changes for Glufast approved in Japan

13-09-2013

Japanese drugmakers Kissei Pharmaceutical (TYO: 4547) and Takeda Pharmaceutical (TYO: 4502) have received…

Asia-PacificDiabetesGlufastKissei PharmaceuticalPharmaceuticalRegulationTakeda Pharmaceuticals

Back to top